Patents by Inventor John Brad Shotwell

John Brad Shotwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzofuran compounds for the treatment of hepatitis C virus infections
    Patent number: 9682999
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: June 20, 2017
    Assignee: Glaxo Group Limited
    Inventors: Pek Yoke Chong, John F. Miller, Andrew James Peat, John Brad Shotwell
  • Benzofuran Compounds For The Treatment Of Hepatitis C Virus Infections
    Publication number: 20150080343
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Application
    Filed: November 20, 2014
    Publication date: March 19, 2015
    Inventors: Pek Yoke Chong, John F. Miller, Andrew James Peat, John Brad Shotwell
  • Benzofuran compounds for the treatment of hepatitis C virus infections
    Patent number: 8927593
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: January 6, 2015
    Assignee: Glaxo Group Limited
    Inventors: Pek Yoke Chong, John Brad Shotwell
  • Benzofuran Compounds For The Treatment Of Hepatitis C Virus Infections
    Publication number: 20130237501
    Abstract: The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Application
    Filed: August 10, 2012
    Publication date: September 12, 2013
    Applicant: Glaxo Group Limited
    Inventors: Pek Yoke Chong, John F. Miller, Andrew James Peat, John Brad Shotwell
  • Imidazopyridine kinase inhibitors
    Patent number: 8093239
    Abstract: The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
    Type: Grant
    Filed: May 28, 2008
    Date of Patent: January 10, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Kevin Kuntz, David Edward Uehling, Alex Gregory Waterson, Kyle Allen Emmitte, Kirk Stevens, John Brad Shotwell, Stephon Cornell Smith, Kristen E. Nailor, James M. Salovich, Brian John Wilson, Mui Cheung, Robert Anthony Mook, Erich W. Baum, Ganesh Moorthy
  • 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer
    Patent number: 7981903
    Abstract: Novel pyrrolopyrimidines as shown in formula (I): and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: July 19, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Stanley Dawes Chamberlain, Felix Deanda, Jr., Roseanne Gerding, Masaichi Hasegawa, Kevin Kuntz, Huangshu Lei, Yasushi Miyazaki, Naohiko Nishigaki, Samarjit Patnaik, Aniko Redman, John Brad Shotwell, Kirk Stevens, Joseph Wilson, Bin Yang
  • Imidazopyridine Kinase Inhibitors
    Publication number: 20100216779
    Abstract: The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
    Type: Application
    Filed: May 28, 2008
    Publication date: August 26, 2010
    Inventors: Eric W. Baum, Kyle Allen Emmitte, Kevin Wayne Kuntz, Robert Anthony Mook, JR., Kristen Elizabeth Nailor, James Michael Salovich, John Brad Shotwell, Stephon Cornell Smith, Kirk Lawrence Stevens, David Edward Uehling, Alex Gregory Waterson, Mui Cheung, Ganesh S. Moorthy, Brian John Wilson
  • 2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer
    Publication number: 20100204196
    Abstract: Novel pyrrolopyrimidines as shown in formula (I): and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
    Type: Application
    Filed: August 6, 2008
    Publication date: August 12, 2010
    Inventors: Stanley Dawes Chamberlain, Felix Deanda, JR., Roseanne Gerding, Masaichi Hasegawa, Kevin Kuntz, Huangshu Lei, Yasushi Miyazaki, Naohiko Nishigaki, Samarjit Patnaik, Aniko Redman, John Brad Shotwell, Kirk Stevens, Joseph Wilson, Bin Yang
  • Imidazopyridine Kinase Inhibitors
    Publication number: 20080300242
    Abstract: The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
    Type: Application
    Filed: May 28, 2008
    Publication date: December 4, 2008
    Inventors: Kevin Kuntz, David Edward Uehling, Alex Gregory Waterson, Kyle Allen Emmitte, Kirk Stevens, John Brad Shotwell, Stephon Cornell Smith, Kristen E. Nailor, James M. Salovich, Brian John Wilson, Mui Cheung, Robert Anthony Mook, Erich W. Baum, Ganesh Moorthy